Yorkville Advisors Global, LP
Position in NRSN — NeuroSense Therapeutics Ltd.
CIK 1838613
Mountainside, NJ
Position in NRSN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$56,160
-$2,730 QoQ
Shares Held
78,000
0.0% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#3
of 12 holders
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRSN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Yorkville Advisors Global, LP holds $178,118 across 2 Biotechnology names. NRSN ranks #2 (31.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNAZ |
Transcode Therapeutics, Inc.
|
19,639 | $121,958 | |
| 2 | NRSN |
NeuroSense Therapeutics Ltd.
This page
|
78,000 | $56,160 |
All Filings in NRSN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $56,160 | 78,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $58,890 | 78,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $76,900 | 100,000 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $113,400 | 60,000 | Shares | Sole | 2025-11-21 | |
| No filing history on record for this holder in this stock. | ||||||